{"schema_version":"secwatch.filing_event.v1","accession":"0000898432-24-000224","form_type":"8-K","ticker":"OSRH","cik":"0001840425","company_name":"OSR Holdings, Inc.","filed_at":"2024-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.910688+00:00","generated_at":"2026-06-04T22:30:41.116165+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Bellevue Life Sciences Acquisition Corp. issues $60K promissory note to Josh Pan for business combination extension","bullets":["On March 8, 2024, Bellevue Life Sciences issued a $60,000 unsecured promissory note to Josh Pan, member of sponsor Bellevue Capital Management, LLC.","Note is non-interest bearing, due August 8, 2024 or upon consummation of an initial business combination, with principal forgiven if no deal occurs.","On March 12, 2024, $60,000 deposited into trust account to extend business combination deadline from March 14, 2024 to April 15, 2024.","Event of default includes payment failure within five business days of maturity or bankruptcy proceedings."],"urls":{"canonical":"https://secwatch.observer/filing/0000898432-24-000224","json":"https://secwatch.observer/filing/0000898432-24-000224.json","markdown":"https://secwatch.observer/filing/0000898432-24-000224.md","text":"https://secwatch.observer/filing/0000898432-24-000224.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840425/000089843224000224/0000898432-24-000224-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840425/000089843224000224/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T22:30:41.116165+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6750806e801535b74abeee19ebc763acabf80aac","claim":"OSR Holdings, Inc. incurred loan of $60,000 with Josh Pan at not interest bearing maturing earlier of: (i) August 8, 2024 or (ii) the date on which the Company consummates an initial business combination.","evidence_excerpt":"On March 8, 2024, Bellevue Life Sciences Acquisition Corp. (the “ Company ”) issued an unsecured promissory note (the “ Promissory Note ”) in the principal amount of $60,000 to Josh Pan","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840425/000089843224000224/0000898432-24-000224-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$60,000"},{"label":"Counterparty","value":"Josh Pan"},{"label":"Rate","value":"not interest bearing"},{"label":"Maturity","value":"earlier of: (i) August 8, 2024 or (ii) the date on which the Company consummates an initial business combination"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}